Literature DB >> 17265712

Technological platforms for microarray gene expression profiling.

Susanna Mandruzzato1.   

Abstract

By using gene microarray technology, scientists can determine in a single experiment, the expression levels of thousands of genes within a given sample. DNA microarray technology is evolving rapidly and there are now numerous high-density platforms available which differ in terms of probe content, design, deposition technology, labeling and hybridization protocols. However, two major platforms for high-density microarray manufacture are in common use. The first utilizes robotic deposition or "spotting" of DNA molecules, while the second uses short oligonucleotides synthesized in situ.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17265712     DOI: 10.1007/978-0-387-39978-2_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Predominance of interferon-related responses in the brain during murine malaria, as identified by microarray analysis.

Authors:  Jenny Miu; Nicholas H Hunt; Helen J Ball
Journal:  Infect Immun       Date:  2008-02-25       Impact factor: 3.441

2.  Role of PKCbeta in hepatocellular carcinoma cells migration and invasion in vitro: a potential therapeutic target.

Authors:  Kun Guo; Yan Li; Xiaonan Kang; Lu Sun; Jiefeng Cui; Dongmei Gao; Yinkun Liu
Journal:  Clin Exp Metastasis       Date:  2008-12-27       Impact factor: 5.150

3.  Prediction of microbial infection of cultured cells using DNA microarray gene-expression profiles of host responses.

Authors:  Yu Rang Park; Tae Su Chung; Young Joo Lee; Yeong Wook Song; Eun Young Lee; Yeo Won Sohn; Sukgil Song; Woong Yang Park; Ju Han Kim
Journal:  J Korean Med Sci       Date:  2012-10-02       Impact factor: 2.153

4.  The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature.

Authors:  Raymon H Grogan; Elliot J Mitmaker; Orlo H Clark
Journal:  Cancers (Basel)       Date:  2010-05-20       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.